125 related articles for article (PubMed ID: 26383841)
1. C60-fullerenes for delivery of docetaxel to breast cancer cells: A promising approach for enhanced efficacy and better pharmacokinetic profile.
Raza K; Thotakura N; Kumar P; Joshi M; Bhushan S; Bhatia A; Kumar V; Malik R; Sharma G; Guru SK; Katare OP
Int J Pharm; 2015 Nov; 495(1):551-559. PubMed ID: 26383841
[TBL] [Abstract][Full Text] [Related]
2. Dextran-PLGA-loaded docetaxel micelles with enhanced cytotoxicity and better pharmacokinetic profile.
Raza K; Kumar N; Misra C; Kaushik L; Guru SK; Kumar P; Malik R; Bhushan S; Katare OP
Int J Biol Macromol; 2016 Jul; 88():206-12. PubMed ID: 27037052
[TBL] [Abstract][Full Text] [Related]
3. Aspartic acid derivatized hydroxylated fullerenes as drug delivery vehicles for docetaxel: an explorative study.
Thotakura N; Sharma G; Singh B; Kumar V; Raza K
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1763-1772. PubMed ID: 29069915
[TBL] [Abstract][Full Text] [Related]
4. Folic acid functionalized long-circulating co-encapsulated docetaxel and curcumin solid lipid nanoparticles: In vitro evaluation, pharmacokinetic and biodistribution in rats.
Pawar H; Surapaneni SK; Tikoo K; Singh C; Burman R; Gill MS; Suresh S
Drug Deliv; 2016 May; 23(4):1453-68. PubMed ID: 26878325
[TBL] [Abstract][Full Text] [Related]
5. Improved cellular uptake, enhanced efficacy and promising pharmacokinetic profile of docetaxel employing glycine-tethered C
Misra C; Thotakura N; Kumar R; Singh B; Sharma G; Katare OP; Raza K
Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():501-508. PubMed ID: 28482557
[TBL] [Abstract][Full Text] [Related]
6. Glycinated fullerenes for tamoxifen intracellular delivery with improved anticancer activity and pharmacokinetics.
Misra C; Kumar M; Sharma G; Kumar R; Singh B; Katare OP; Raza K
Nanomedicine (Lond); 2017 May; 12(9):1011-1023. PubMed ID: 28440713
[TBL] [Abstract][Full Text] [Related]
7. In vivo pharmacokinetic studies and intracellular delivery of methotrexate by means of glycine-tethered PLGA-based polymeric micelles.
Madhwi ; Kumar R; Kumar P; Singh B; Sharma G; Katare OP; Raza K
Int J Pharm; 2017 Mar; 519(1-2):138-144. PubMed ID: 28093326
[TBL] [Abstract][Full Text] [Related]
8. C60-fullerenes as Drug Delivery Carriers for Anticancer Agents: Promises and Hurdles.
Kumar M; Raza K
Pharm Nanotechnol; 2017; 5(3):169-179. PubMed ID: 29361902
[TBL] [Abstract][Full Text] [Related]
9. Conjugation of Docetaxel with Multiwalled Carbon Nanotubes and Codelivery with Piperine: Implications on Pharmacokinetic Profile and Anticancer Activity.
Raza K; Kumar D; Kiran C; Kumar M; Guru SK; Kumar P; Arora S; Sharma G; Bhushan S; Katare OP
Mol Pharm; 2016 Jul; 13(7):2423-32. PubMed ID: 27182646
[TBL] [Abstract][Full Text] [Related]
10. Aspartic acid tagged carbon nanotubols as a tool to deliver docetaxel to breast cancer cells: Reduced hemotoxicity with improved cytotoxicity.
Thotakura N; Sharma S; Khurana RK; Babu PV; Chitkara D; Kumar V; Singh B; Raza K
Toxicol In Vitro; 2019 Sep; 59():126-134. PubMed ID: 30986424
[TBL] [Abstract][Full Text] [Related]
11. PEI-derivatized fullerene drug delivery using folate as a homing device targeting to tumor.
Shi J; Zhang H; Wang L; Li L; Wang H; Wang Z; Li Z; Chen C; Hou L; Zhang C; Zhang Z
Biomaterials; 2013 Jan; 34(1):251-61. PubMed ID: 23069706
[TBL] [Abstract][Full Text] [Related]
12. Chitosan Engineered PAMAM Dendrimers as Nanoconstructs for the Enhanced Anti-Cancer Potential and Improved In vivo Brain Pharmacokinetics of Temozolomide.
Sharma AK; Gupta L; Sahu H; Qayum A; Singh SK; Nakhate KT; Ajazuddin ; Gupta U
Pharm Res; 2018 Jan; 35(1):9. PubMed ID: 29294212
[TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization and evaluation of docetaxel-loaded, folate-conjugated PEG-liposomes.
Yuan Z; Chen D; Zhang S; Zheng Z
Yakugaku Zasshi; 2010 Oct; 130(10):1353-9. PubMed ID: 20930488
[TBL] [Abstract][Full Text] [Related]
14. Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.
Bu X; Zhu T; Ma Y; Shen Q
Drug Dev Ind Pharm; 2015 May; 41(5):764-71. PubMed ID: 24669977
[TBL] [Abstract][Full Text] [Related]
15. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system.
Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO
J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664
[TBL] [Abstract][Full Text] [Related]
16. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
17. Development of docetaxel nanocapsules for improving in vitro cytotoxicity and cellular uptake in MCF-7 cells.
Singh SK; Banala VT; Gupta GK; Verma A; Shukla R; Pawar VK; Tripathi P; Mishra PR
Drug Dev Ind Pharm; 2015; 41(11):1759-68. PubMed ID: 25686725
[TBL] [Abstract][Full Text] [Related]
18. Dendrimer encapsulated and conjugated delivery of berberine: A novel approach mitigating toxicity and improving in vivo pharmacokinetics.
Gupta L; Sharma AK; Gothwal A; Khan MS; Khinchi MP; Qayum A; Singh SK; Gupta U
Int J Pharm; 2017 Aug; 528(1-2):88-99. PubMed ID: 28533175
[TBL] [Abstract][Full Text] [Related]
19. Cellular cytotoxicity and in-vivo biodistribution of docetaxel poly(lactide-co-glycolide) nanoparticles.
Esmaeili F; Dinarvand R; Ghahremani MH; Ostad SN; Esmaily H; Atyabi F
Anticancer Drugs; 2010 Jan; 21(1):43-52. PubMed ID: 19809300
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of co-formulated docetaxel and curcumin biodegradable nanoparticles for parenteral administration.
Pawar H; Wankhade SR; Yadav DK; Suresh S
Pharm Dev Technol; 2016 Sep; 21(6):725-36. PubMed ID: 26330159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
